Chemoinformaics analysis of Trans-5-Hydroxy-L-Pipecolic-Acid
| Molecular Weight | 145.158 | nRot | 1 |
| Heavy Atom Molecular Weight | 134.07 | nRig | 7 |
| Exact Molecular Weight | 145.074 | nRing | 1 |
| Solubility: LogS | -0.579 | nHRing | 1 |
| Solubility: LogP | -2.531 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 20.8607 |
| nHD | 3 | BPOL | 12.4733 |
| QED | 0.451 |
| Synth | 3.361 |
| Natural Product Likeliness | 1.51 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.539 |
| CACO-2 | -5.977 |
| MDCK | 0.000387331 |
| BBB | 0.448 |
| PPB | 0.0871257 |
| VDSS | 0.528 |
| FU | 0.900502 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.057 |
| CYP2c19-inh | 0.04 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.233 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.226 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.023 |
| CL | 4.867 |
| T12 | 0.711 |
| hERG | 0.014 |
| Ames | 0.009 |
| ROA | 0.037 |
| SkinSen | 0.239 |
| Carcinogencity | 0.083 |
| EI | 0.105 |
| Respiratory | 0.338 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.952995 |